Reverse vaccinology project, predicting the potential vaccine candidates using many different approaches against bovine pathogens.
Sepsis Biomarker Signature: Multicenter Research Study
Reverse Vaccinology project. Protein expression and purification.
Transcriptomic analysis, Transposon insertion sequencing analysis, Luminex analysis.
Using novel peptides as an adjunctive treatment against multi-drug antibiotic resistant organisms.
More about Dr. Hancock
Network-based approaches to integrating patient transcriptome and clinical data.
Outer membrane proteins in Pseudomonas aeruginosa. Cloning, function and crystallization.
In vivo immunomodulatory peptide studies and anti-biofilm.
Exploring antimicrobial peptide and antibiotic susceptibility of drug resistant pathogens in host-mimicking conditions.
Infectious diseases and their respective pathogens. Swarming motility and antibiotic resistance in Pseudomonas aeruginosa, a cystic fibrosis and nosocomial pathogen.
Genes regulating adaptive antibiotic resistance within Pseudomonas aeruginosa biofilms.
Transcriptomic analysis of RNAseq data; Bioinformatics
Design and Sequence Optimization of Innate Defence Regulator Peptides.
Integrative Analysis of Transcriptomic and Metabolomic Data in Sepsis Patients.
Transcriptomic analysis/Reverse Vaccinology of Johne’s disease
Inhibition of S.aureus biofilms
Investigating the mechanism of action of anti-biofilm peptides in vitro and in vivo (using a cutaneous abscess model established for Gram-negative bacteria) in Pseudomonas aeruginosa
System administrator at Tekworks
Designing improved anti-infective peptides
Surfing motility as a complex adaptation.
Investigating the effect of antimicrobial peptide on bacterial cell division
Inhibition of swarming motility.
Host defense peptides and toxin-sequestration, liposomal therapy for the use in anti-infective therapy.
Mechanism of anti-inflammatory peptide IDR-1002 in vitro and in vivo.
Using synthetic host defence peptides against Pseudomonas aeruginosa lung infections.